We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

1 hedge funds and large institutions have $78.3K invested in Global Cord Blood Corporation in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more capital invested

Capital invested by funds: $51.5K → $78.3K (+$26.9K)

0% more funds holding

Funds holding: 11 (0)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$78.3K

CO Hedge Fund Activity: Q3 2024 in Review

1 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2024, worth a combined $78.3K — up 52% from $51.5K a quarter earlier.

Fund positioning in CO was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Global Cord Blood Corporation (CO) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $78.3K of Global Cord Blood Corporation stock for Q3 2024, up 52% quarter-over-quarter.
  • 0 funds opened new Global Cord Blood Corporation positions in Q3 2024 and 0 closed out.

Based on aggregated 13F filings for Q3 2024.